RecruitingNot ApplicableNCT01558544

Cryopreservation of Ovarian Tissue

Cryopreservation of Ovarian Tissue for Potential In Vitro Maturation or Autologous Transplantation

Sponsor

Weill Medical College of Cornell University

Enrollment

300 participants

Start Date

Apr 1, 1997

Study Type

INTERVENTIONAL

Conditions

Cancer Fertility Preservation Risk of Premature Ovarian Failure

Summary

The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.

Eligibility

Sex: FEMALEMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study offers the option of freezing ovarian tissue before medical treatments that are likely to cause early menopause or loss of fertility, so that the tissue may potentially be used in the future to restore hormone function or the ability to have children. **You may be eligible if...** - You are a female between 0 and 45 years old and have not yet gone through natural menopause - You are about to undergo a treatment likely to cause early menopause, such as cancer treatment with high-dose chemotherapy or pelvic radiation, or surgery to remove the ovaries for a medical reason (for example, if you carry the BRCA gene mutation) - You are unable or unwilling to freeze eggs or embryos as an alternative **You may NOT be eligible if...** - You have already gone through menopause - You are over 45 years old - Your planned treatment is not likely to affect your ovarian function Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.